Benzinga’s Top Pre-Market Gainers (AIPC, EXEL, CRUS, GXDX)

American Italian Pasta Company AIPC soared 26.29% to $52.7 in the pre-market session. AIPC is about to be acquired by snacks company Ralcorp Holdings Inc RAH in an all cash deal valued at $1.2 billion, or $53 a share. Exelixis Inc EXEL added 4.8% to $4.8 in pre-market trading. The biotech company got back all rights from Bristol-Myers Squibb Company BMY to develop and commercialize cancer drug XL184. Cirrus Logic Inc CRUS moved up 4.66% to $18.65 in pre-market trading. The semiconductor company hit a new 52 week high on Friday at $17.82, up 4.82%. Genoptix Inc GXDX gained 3.60% to $17.27 in the pre-market session. Today, analysts at Auriga upgraded GXDX from “sell” to “hold.” Read more from Benzinga's Markets.